Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Sindrup

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Clinical Pharmacology|November 1, 1990
Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over studyS H Sindrup, L F Gram, T Skjold, et al.
Pain|March 1, 1995
The hypoalgesic effect of imipramine in different human experimental pain modelsL Poulsen, L Arendt-Nielsen, K Brøsen, et al.
Journal of Neurology|July 1, 1994
Inter-observer variation in the evaluation of neurological signs: patient-related factorsM Hansen, P B Christensen, S H Sindrup, et al.
Acta Neurologica Scandinavica|September 1, 1994
Interobserver variation in the evaluation of neurological signs: observer dependent factorsM Hansen, S H Sindrup, P B Christensen, et al.
European Journal of Pain (London, England)|May 31, 2017
Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathyS H Sindrup, J Holbech, D Demant, et al.
European Journal of Neurology|January 28, 2014
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studiesT Krøigård, H D Schrøder, C Qvortrup, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Lack of effect of mianserin on the symptoms of diabetic neuropathyS H Sindrup, C Tuxen, L F Gram, et al.
BMJ (Clinical Research Ed.)|June 6, 1998
Inappropriate use of sumatriptan: population based register and interview studyD Gaist, I Tsiropoulos, S H Sindrup, et al.
Therapeutic Drug Monitoring|February 1, 1993
Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphismsS H Sindrup, K Brøsen, M G Hansen, et al.
European Journal of Clinical Pharmacology|May 1, 2009
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarkerL Noehr-Jensen, S T Zwisler, F Larsen, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|November 1, 1990
Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over studyS H Sindrup, L F Gram, T Skjold, et al.
Pain|March 1, 1995
The hypoalgesic effect of imipramine in different human experimental pain modelsL Poulsen, L Arendt-Nielsen, K Brøsen, et al.
Journal of Neurology|July 1, 1994
Inter-observer variation in the evaluation of neurological signs: patient-related factorsM Hansen, P B Christensen, S H Sindrup, et al.
Acta Neurologica Scandinavica|September 1, 1994
Interobserver variation in the evaluation of neurological signs: observer dependent factorsM Hansen, S H Sindrup, P B Christensen, et al.
European Journal of Pain (London, England)|May 31, 2017
Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathyS H Sindrup, J Holbech, D Demant, et al.
European Journal of Neurology|January 28, 2014
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studiesT Krøigård, H D Schrøder, C Qvortrup, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Lack of effect of mianserin on the symptoms of diabetic neuropathyS H Sindrup, C Tuxen, L F Gram, et al.
BMJ (Clinical Research Ed.)|June 6, 1998
Inappropriate use of sumatriptan: population based register and interview studyD Gaist, I Tsiropoulos, S H Sindrup, et al.
Therapeutic Drug Monitoring|February 1, 1993
Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphismsS H Sindrup, K Brøsen, M G Hansen, et al.
European Journal of Clinical Pharmacology|May 1, 2009
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarkerL Noehr-Jensen, S T Zwisler, F Larsen, et al.
Pageof 8